Jordan TimesImmunotherapy succeeds in thwarting Type 1 diabetesJordan TimesA form of immunotherapy gaining ground as a way to treat childhood food allergies has shown promise in treating another rising scourge of children and young adults: Type 1 diabe… Continue reading
Biosecurity and synthetic biology: it is time to get seriousPLoS Blogs (blog)Last month, the SB7.0 conference attracted around 800 synthetic biology experts from all around the world to Singapore. I was attending as part of the SB7.0 biosecurity fellow… Continue reading
Mouse model of human immune system inadequate for stem cell studiesScience DailyA type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a s… Continue reading
Mouse model of human immune system inadequate for stem cell studiesScience DailyA type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a s… Continue reading
|
Breakthrough cancer drug could be astronomical in price
USA TODAY The treatment, CTL019, belongs to a new class of medications called CAR T-cell therapies, which involve harvesting patients’ immune cells and genetically altering them to kill cancer. It’s been tested in patients whose leukemia has relapsed in spite of … |
|
Stem Cell Therapy for Infections by Resilient Bacteria
Financial Tribune “Sometimes ulcers which are resistant to conventional treatment, respond positively and swiftly to stem cell treatments,” he explained, adding that officials from Council for Stem Cell Sciences and Technologies (affiliated to Vice-Presidency for … |
|
Doctor on new cancer treatment: ‘genetically engineered, tumor-killing factory’
The Business Journal CTL019, a CAR T-cell therapy from the pharmaceutical company Novartis, was recommended unanimously last month, and doctors in the Central Valley have taken notice. One person to welcome the therapy is Saint Agnes Cancer Center oncologist Dr. Ravi … |
|
Doctor on new cancer treatment: ‘genetically engineered, tumor-killing factory’
The Business Journal CTL019, a CAR T-cell therapy from the pharmaceutical company Novartis, was recommended unanimously last month, and doctors in the Central Valley have taken notice. One person to welcome the therapy is Saint Agnes Cancer Center oncologist Dr. Ravi … |